GRX logo

The Gabelli Healthcare & Wellness Trust

GRXNYSE
US Equity
$9.92β–² $0.00 (+0.00%)
Market closed Β· at close
1hβ€”
24hβ–² 0.0%
7dβ–² 1.5%
14dβ–² 1.3%
30dβ–² 4.0%
1yβ–² 7.1%
🏦Market Cap
$147B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
+11.0%
Healthy
πŸ“ŠGross Margin
49.1%
Healthy
πŸ’΅FCF Margin
11.0%
Healthy
βš–οΈP/S Ratio
8.4x
Elevated
Otter Score
55
Weak

Trading Snapshot

Day Range
$9.77 – $10.03
52-Week Range
$75.82 – $220.25
Volume
$1.76B
Avg Volume
$1.77B
Shares Outstanding
14.82B
Next Earnings
Sep 8, 2026

Fundamentals Snapshot

Annual Revenue
$15M
Last Q Revenue
$6M
P/E Ratio
46.2
P/S Ratio
8.4x
EPS (TTM)
$3.12
Dividend Yield
1.00%

Why Investors Own GRX

  • βœ“High-growth profile β€” revenue up +11.0% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 49% gross margin and 11% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$15Mβ–² +10.4% YoY
Gross Margin (TTM)
49.1%β–² +2.0% YoY
Operating Income (TTM)
$5Mβ–² +10.4% YoY
Free Cash Flow (TTM)
$2Mβ–² +10.4% YoY

About The Gabelli Healthcare & Wellness Trust

A company profile for The Gabelli Healthcare & Wellness Trust isn’t available yet β€” check back soon.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
55/100

Analyst Price Target

β“˜
Average Target
$9.81
β–Ό βˆ’1.1% Downside
High Target$11.66
Low Target$9.02
Based on 15 analysts

Latest News & Updates